Imaging adjuvants in pediatric surgical oncology

Author:

Fusco Joseph C.1,Abdelhafeez Abdelhafeez H.2ORCID,Krauel Lucas3,Honeyman Joshua N.4,Ehrlich Peter F.5,Wijnen Marc6,Lautz Timothy B.7ORCID,Pachl Max8ORCID,Malek Marcus M.9ORCID

Affiliation:

1. Department of Pediatric Surgery Monroe Carell Jr. Children's Hospital, Vanderbilt University Nashville Tennessee USA

2. Department of Surgery St. Jude Children's Research Hospital Memphis Tennessee USA

3. Department of Surgery St. Joan de Deu Barcelona Children's Hospital Barcelona Spain

4. Department of Surgery Memorial Sloan Kettering Cancer Center New York New York USA

5. Division of Pediatric Surgery C.S. Mott Children's Hospital, University of Michigan Ann Arbor Michigan USA

6. Department of Pediatric Surgery Princess Maxima Center for Pediatric Oncology Utrecht Netherlands

7. Department of Surgery Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Chicago Illinois USA

8. Department of Surgery Birmingham Women's and Children's NHS Foundation Trust Birmingham UK

9. Division of Pediatric General and Thoracic Surgery University of Pittsburgh Pittsburgh Pennsylvania USA

Abstract

AbstractSurgery is a crucial component of pediatric cancer treatment, but conventional methods may lack precision. Image‐guided surgery, including fluorescent and radioguided techniques, offers promise for enhancing tumor localization and facilitating precise resection. Intraoperative molecular imaging utilizes agents like indocyanine green to direct surgeons to occult deposits of tumor and to delineate tumor margins. Next‐generation agents target tumors directly to improve specificity. Radioguided surgery, employing tracers like metaiodobenzylguanidine (MIBG), complements fluorescent techniques by allowing for detection of tumors at a greater depth. Dual‐labeled agents combining both modalities are under development. Three‐dimensional modeling and virtual/augmented reality aid in preoperative planning and intraoperative guidance. The above techniques show great promise to benefit patients with pediatric tumors, and their continued development will almost certainly improve surgical outcomes.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3